Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Onconetix (ONCO) Consolidated Net Income (2023 - 2025)

Historic Consolidated Net Income for Onconetix (ONCO) over the last 3 years, with Q3 2025 value amounting to -$8.8 million.

  • Onconetix's Consolidated Net Income fell 12949.5% to -$8.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$49.1 million, marking a year-over-year increase of 479.69%. This contributed to the annual value of -$58.7 million for FY2024, which is 5688.72% down from last year.
  • As of Q3 2025, Onconetix's Consolidated Net Income stood at -$8.8 million, which was down 12949.5% from -$2.4 million recorded in Q2 2025.
  • Onconetix's Consolidated Net Income's 5-year high stood at -$2.4 million during Q2 2025, with a 5-year trough of -$29.4 million in Q4 2024.
  • Its 3-year average for Consolidated Net Income is -$10.5 million, with a median of -$8.5 million in 2025.
  • Its Consolidated Net Income has fluctuated over the past 5 years, first plummeted by 29058.53% in 2024, then surged by 8341.75% in 2025.
  • Quarter analysis of 3 years shows Onconetix's Consolidated Net Income stood at -$22.4 million in 2023, then crashed by 31.64% to -$29.4 million in 2024, then skyrocketed by 70.16% to -$8.8 million in 2025.
  • Its Consolidated Net Income stands at -$8.8 million for Q3 2025, versus -$2.4 million for Q2 2025 and -$8.5 million for Q1 2025.